South Africa Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
South Africa Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
Summary
Pharmaceuticals in South Africa industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Summary
Pharmaceuticals in South Africa industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The South African pharmaceuticals market had total revenues of $4.8 billion in 2022, representing a compound annual growth rate (CAGR) of 5.3% between 2017 and 2022.
- 0
- According to the National Treasury (Republic of South Africa), the total health expenditure estimates were ZAR4,772.2 million ($322.7 million) in 2022-23, which includes communicable and non-communicable, diseases, primary healthcare, hospital systems, etc.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in South Africa
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in South Africa
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the South Africa pharmaceuticals market with five year forecasts by both value and volume
- What was the size of the South Africa pharmaceuticals market by value in 2022?
- What will be the size of the South Africa pharmaceuticals market in 2027?
- What factors are affecting the strength of competition in the South Africa pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in South Africa's pharmaceuticals market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of leading players?
7.3. What strategies do leading players follow?
8 COMPANY PROFILES
8.1. Aspen Pharmacare Holdings Ltd
8.2. Adcock Ingram Holdings Ltd
8.3. Sanofi SA
8.4. Novartis AG
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of leading players?
7.3. What strategies do leading players follow?
8 COMPANY PROFILES
8.1. Aspen Pharmacare Holdings Ltd
8.2. Adcock Ingram Holdings Ltd
8.3. Sanofi SA
8.4. Novartis AG
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: South Africa pharmaceuticals market value: $ billion, 2017-22
Table 2: South Africa pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: South Africa pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Aspen Pharmacare Holdings Ltd: key facts
Table 5: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 6: Aspen Pharmacare Holdings Ltd: Key Employees
Table 7: Adcock Ingram Holdings Ltd: key facts
Table 8: Adcock Ingram Holdings Ltd: Annual Financial Ratios
Table 9: Adcock Ingram Holdings Ltd: Key Employees
Table 10: Sanofi SA: key facts
Table 11: Sanofi SA: Annual Financial Ratios
Table 12: Sanofi SA: Key Employees
Table 13: Sanofi SA: Key Employees Continued
Table 14: Novartis AG: key facts
Table 15: Novartis AG: Annual Financial Ratios
Table 16: Novartis AG: Key Employees
Table 17: Novartis AG: Key Employees Continued
Table 18: South Africa size of population (million), 2018-22
Table 19: South Africa gdp (constant 2005 prices, $ billion), 2018-22
Table 20: South Africa gdp (current prices, $ billion), 2018-22
Table 21: South Africa inflation, 2018-22
Table 22: South Africa consumer price index (absolute), 2018-22
Table 23: South Africa exchange rate, 2018-22
Table 1: South Africa pharmaceuticals market value: $ billion, 2017-22
Table 2: South Africa pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: South Africa pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Aspen Pharmacare Holdings Ltd: key facts
Table 5: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 6: Aspen Pharmacare Holdings Ltd: Key Employees
Table 7: Adcock Ingram Holdings Ltd: key facts
Table 8: Adcock Ingram Holdings Ltd: Annual Financial Ratios
Table 9: Adcock Ingram Holdings Ltd: Key Employees
Table 10: Sanofi SA: key facts
Table 11: Sanofi SA: Annual Financial Ratios
Table 12: Sanofi SA: Key Employees
Table 13: Sanofi SA: Key Employees Continued
Table 14: Novartis AG: key facts
Table 15: Novartis AG: Annual Financial Ratios
Table 16: Novartis AG: Key Employees
Table 17: Novartis AG: Key Employees Continued
Table 18: South Africa size of population (million), 2018-22
Table 19: South Africa gdp (constant 2005 prices, $ billion), 2018-22
Table 20: South Africa gdp (current prices, $ billion), 2018-22
Table 21: South Africa inflation, 2018-22
Table 22: South Africa consumer price index (absolute), 2018-22
Table 23: South Africa exchange rate, 2018-22
LIST OF FIGURES
Figure 1: South Africa pharmaceuticals market value: $ billion, 2017-22
Figure 2: South Africa pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: South Africa pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in South Africa, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in South Africa, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in South Africa, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Africa, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in South Africa, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in South Africa, 2022
Figure 1: South Africa pharmaceuticals market value: $ billion, 2017-22
Figure 2: South Africa pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: South Africa pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in South Africa, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in South Africa, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in South Africa, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Africa, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in South Africa, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in South Africa, 2022
